Posted on
The American Academy of Neurology recently published new guidelines, “Intravenous Immunoglobulin in the Treatment of Neuromuscular Disorders” on the efficacy of IVIg treatments in GBS, CIDP, MMN, and other neuromuscular disorder patients.